Cas:17273-89-1 sodium,cyclopentanecarboxylate manufacturer & supplier

We serve Chemical Name:sodium,cyclopentanecarboxylate CAS:17273-89-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

sodium,cyclopentanecarboxylate

Chemical Name:sodium,cyclopentanecarboxylate
CAS.NO:17273-89-1
Synonyms:UNII-41AI9Y93Q6;Nusope 33A;Sodium cyclopentane carboxylate
Molecular Formula:C6H9NaO2
Molecular Weight:136.12400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:40.13000
Exact Mass:136.05000
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like UNII-41AI9Y93Q6 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sodium cyclopentane carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,UNII-41AI9Y93Q6 Use and application,Nusope 33A technical grade,usp/ep/jp grade.


Related News: In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. sodium,cyclopentanecarboxylate manufacturer ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States. sodium,cyclopentanecarboxylate supplier ��The number of confirmed cases of coronavirus in Taiwan is not higher than in most countries affected,�� Mr. Wu said. ��Other than China, no other country, no other country has had its flight banned by Italy.�� sodium,cyclopentanecarboxylate vendor In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. sodium,cyclopentanecarboxylate factory Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.